[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"fda-events-search:[\"\",\"\",\"MIX\",\"1990-01-01\",\"2026-11-17\",1]":3,"fda-latest-sync-dates":38},{"events":4,"total":37},[5,26],{"mdr_report_key":6,"report_number":7,"event_type":8,"date_received":9,"date_of_event":10,"report_source_code":11,"adverse_event_flag":12,"product_problem_flag":13,"product_problems":14,"brand_name":16,"generic_name":17,"product_code":18,"manufacturer_name":19,"model_number":20,"patient_outcomes":21,"remedial_action":24,"created_at":25,"updated_at":25},"24200235","3013840437-2026-00014","Injury","2026-01-28","2025-12-18","Manufacturer report","Y","N",[15],"Adverse Event Without Identified Device or Use Problem","PROLARYN GEL","SYSTEM, VOCAL CORD MEDIALIZATION","MIX","MERZ NORTH AMERICA, INC (FRANKSVILLE)","",[22,23],"Required Intervention"," O",[20],"2026-07-16T09:03:11.79894+00:00",{"mdr_report_key":27,"report_number":28,"event_type":8,"date_received":29,"date_of_event":30,"report_source_code":11,"adverse_event_flag":12,"product_problem_flag":13,"product_problems":31,"brand_name":16,"generic_name":17,"product_code":18,"manufacturer_name":19,"model_number":20,"patient_outcomes":32,"remedial_action":35,"created_at":36,"updated_at":36},"24179121","3013840437-2026-00189","2026-01-26",null,[15],[33,34],"Other"," R",[20],"2026-07-16T09:04:24.000038+00:00",2,{"510k":39,"classification":40,"enforcement":41,"event":42,"event_backfill":43,"pma":44,"warning_letter":45},"2026-11-16T02:00:55.89+00:00","2026-11-16T02:00:41.999+00:00","2026-11-16T02:00:49.415+00:00","2026-11-17T04:00:34.414+00:00","2026-09-07T05:17:28.839+00:00","2026-11-16T02:01:03.155+00:00","2026-11-17T01:02:55.859+00:00"]